Volume | 756,553 |
|
|||||
News | (2) | ||||||
Day High | 16.71 | Low High |
|||||
Day Low | 15.75 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Tarsus Pharmaceuticals Inc | TARS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
16.71 | 15.75 | 16.71 | 15.86 | 16.53 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
7,287 | 756,553 | $ 16.06 | $ 12,147,081 | - | 11.33 - 25.25 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:53:10 | 2 | $ 16.20 | USD |
Tarsus Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
524.71M | 33.10M | - | 25.82M | -62.09M | -1.88 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Tarsus Pharmaceuticals News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TARS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 17.50 | 17.98 | 15.75 | 16.68 | 535,385 | -1.27 | -7.26% |
1 Month | 14.93 | 19.34 | 14.87 | 17.01 | 715,101 | 1.30 | 8.71% |
3 Months | 15.49 | 19.34 | 12.57 | 16.09 | 534,157 | 0.74 | 4.78% |
6 Months | 16.84 | 25.25 | 12.57 | 17.24 | 467,966 | -0.61 | -3.62% |
1 Year | 16.81 | 25.25 | 11.33 | 16.74 | 293,057 | -0.58 | -3.45% |
3 Years | 24.35 | 63.69 | 10.8001 | 18.58 | 151,007 | -8.12 | -33.35% |
5 Years | 18.30 | 63.69 | 10.8001 | 18.65 | 148,036 | -2.07 | -11.31% |
Tarsus Pharmaceuticals Description
Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. |